Evidence of multifocality of telomere erosion in high-grade prostatic intraepithelial neoplasia (HPIN) and concurrent carcinoma

Oncogene

Volumn 22, Issue 13, 2003, Pages 1978-1987

  Vukovic, Bisera ^a,b   Park, Paul C ^a   Al Maghrabi, Jaudah ^a,b   Beheshti, Ben ^a,b   Sweet, Joan ^b,c   Evans, Andy ^b,c   Trachtenberg, John ^c   Squire, Jeremy ^a,b  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Heterogeneity; Prostate; Telomere

Indexed keywords

PEPTIDE NUCLEIC ACID; KI 67 ANTIGEN; PARAFFIN; PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER GROWTH; CARCINOGENESIS; CARCINOMA IN SITU; CHROMOSOME ABERRATION; CHROMOSOME NUMBER; CHROMOSOME STRUCTURE; CLINICAL ARTICLE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN TISSUE; PRECANCER; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATE EPITHELIUM; PROSTATECTOMY; TELOMERE; ADENOCARCINOMA; AGING; ANEUPLOIDY; CELL TRANSFORMATION; CHEMISTRY; DISEASE COURSE; ENZYME IMMUNOASSAY; GENETICS; IMAGE PROCESSING; INTERPHASE; MALE; MIDDLE AGED; PROSTATE TUMOR; PROSTATIC INTRAEPITHELIAL NEOPLASIA; ULTRASTRUCTURE;

ADENOCARCINOMA; AGED; AGING; ANEUPLOIDY; CELL TRANSFORMATION, NEOPLASTIC; CHROMOSOME ABERRATIONS; DISEASE PROGRESSION; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOENZYME TECHNIQUES; IN SITU HYBRIDIZATION, FLUORESCENCE; INTERPHASE; KI-67 ANTIGEN; MALE; MIDDLE AGED; PARAFFIN EMBEDDING; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS; TELOMERE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0037417131     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206227     Document Type: Article

References (59)

1. Al-Maghrabi J, Vorobyova L, Chapman W, Jewett M, Zielenska M and Squire JA. (2001). Mod. Pathol., 14, 1252-1262.
2. Al-Maghrabi J, Vorobyova L, Toi A, Chapman W, Zielenska M and Squire JA. (2002). Arch. Pathol. Lab. Med., 126, 165-169.
3. Artandi SE and DePinho RA. (2000). Curr. Opin. Genet. Dev., 10, 39-46.
4. Baas IO, Mulder JW, Offerhaus GJ, Vogelstein B and Hamilton SR. (1994). J. Pathol., 172, 5-12.
5. Bastacky SI, Wojno KJ, Walsh PC, Carmichael MJ and Epstein JI. (1995). J. Urol., 153, 987-992.
6. Beheshti B, Park PC, Sweet JM, Trachtenberg J, Jewett MA and Squire JA. (2001). Neoplasia., 3, 62-69.
7. Bohr V, Anson RM, Mazur S and Dianov G. (1998). Toxicol. Lett., 102-103, 47-52.
8. Bonkhoff H, Stein U and Remberger K. (1994). Prostate, 24, 114-118.
9. Bonsing BA, Corver WE, Gorsira MC, van Vliet M, Oud PS, Cornelisse CJ and Fleuren GJ. (1997). Cytometry, 28, 11-24.
10. Bostwick DG, Shan A, Qian J, Darson M, Maihle NJ, Jenkins RB and Cheng L. (1998). Cancer, 83, 1995-2002.
11. Campbell C, Quinn AG, Angus B and Rees JL. (1993). Br. J. Dermatol., 129, 235-241.
12. Cheng L, Song SY, Pretlow TG, Abdul-Karim FW, Kung HJ, Dawson DV, Park WS, Moon YW, Tsai ML, Linehan WM, Emmert-Buck MR, Liotta LA and Zhuang Z. (1998). J. Natl. Cancer Inst., 90, 233-237.
13. Coleman WB and Tsongalis GJ. (1995). Clin Chem., 41, 644-657.
14. Counter CM. (1996). Mutat. Res., 366, 45-63.
15. Cunningham JM, Shan A, Wick MJ, McDonnell SK, Schaid DJ, Tester DJ, Qian J, Takahashi S, Jenkins RB, Bostwick DG and Thibodeau SN. (1996). Cancer Res., 56, 4475-4482.
16. Dong JT, Isaacs WB and Isaacs JT. (1997). Curr. Opin. Oncol., 9, 101-107.
17. Ducray C, Pommier JP, Martins L, Boussin FD and Sabatier L. (1999). Oncogene, 18, 4211-4223.
18. Emmert-Buck MR, Vocke CD, Pozzatti RO, Duray PH, Jennings SB, Florence CD, Zhuang Z, Bostwick DG, Liotta LA and Linehan WM. (1995). Cancer Res., 55, 2959-2962.
19. Erbersdobler A, Bardenhagen P and Henke RP. (1999). Prostate, 38, 92-99.
20. Erbersdobler A, Gurses N and Henke RP. (1996). Pathol. Res. Pract., 192, 418-427.
21. Foster CS, Bostwick DG, Bonkhoff H, Damber JE, van der Kwast T, Montironi R and Sakr WA. (2000). Scand. J. Urol. Nephrol. Suppl., 19-43.
22. Giaretti W and Santi L. (1990). Int. J. Cancer, 45, 597-603.
23. Goyns MH and Lavery WL. (2000). Mech. Ageing Dev., 114, 69-77.
24. Graham Jr SD, Bostwick DG, Hoisaeter A, Abrahamsson P, Algaba F, di Sant'Agnese A, Mostofi FK and Napalkov P. (1992). Cancer, 70, 359-361.
25. Grobelny JV, Kulp-McEliece M, Broccoli D. (2001). Hum. Mol. Genet., 10, 1953-1961.
26. Haas GP and Sakr WA. (1997). CA Cancer J. Clin., 47, 273-287.
27. Hande MP, Samper E, Lansdorp P and Blasco MA. (1999). J. Cell Biol., 144, 589-601.
28. Harding MA and Theodorescu D. (2000). 5, 258-264.
29. Harley CB. (1991). Mutat. Res., 256, 271-282.
30. Hixon ML and Gualberto A. (2000). Front Biosci., 5, D50-D57.
31. Isaacs WB, Bova GS, Morton RA, Bussemakers MJ, Brooks JD and Ewing CM. (1994). Semin. Oncol., 21, 514-521.
32. Kallakury BV, Brien TP, Lowry CV, Muraca PJ, Fisher HA, Kaufman Jr RP and Ross JS. (1997). Diag. Mol. Pathol., 6, 192-198.
33. Koeneman KS, Pan CX, Jin JK, Pyle III JM, Flanigan RC, Shankey TV and Diaz MO. (1998). J. Urol., 160, 1533-1539.
34. Lin Y, Uemura H, Fujinami K, Hosaka M, Harada M and Kubota Y. (1997). J. Urol., 157, 1161-1165.
35. Macoska JA, Trybus TM, Sakr WA, Wolf MC, Benson PD, Powell IJ and Pontes JE. (1994). Cancer Res., 54, 3824-3830.
36. McClintock B. (1941). Genetics, 26, 234-282.
37. McNeal J and Bostwick DG. (1986). Hum. Pathol., 17.
38. Meeker AK, Gage WR, Hicks JL, Simon I, Coffman JR, Platz EA, March GE and De Marzo AM. (2002). Am. J. Pathol., 160, 1259-1268.
39. Morgan WF, Corcoran J, Hartmann A, Kaplan MI, Limoli CL and Ponnaiya B. (1998). Mutat. Res., 404, 125-128.
40. Muir CS, Nectoux J and Staszewski J. (1991). Acta Oncol., 30, 133-140.
41. Muller H. (1938). Collecting Net, 13, 183-195.
42. Olovnikov AM. (1973). J. Theor. Biol., 41, 181-190.
43. Poon SS, Martens UM, Ward RK and Lansdorp PM. (1999). Cytometry, 36, 267-278.
44. Qian J, Jenkins RB and Bostwick DG. (1995). Urology, 46, 837-842.
45. Qian J, Jenkins RB and Bostwick DG. (1999). Eur. Urol., 35, 479-483.
46. Rasnick D and Duesberg PH. (1999). Biochem. J., 340 (Part 3), 621-630.
47. Sakr WA and Grignon DJ. (1998). Anal. Quant. Cytol. Histol., 20, 417-423.
48. Sakr WA, Grignon DJ, Haas GP, Heilbrun LK, Pontes JE and Crissman JD. (1996). Eur. Urol., 30, 138-144.
49. Sakr WA, Grignon DJ, Haas GP, Schomer KL, Heilbrun LK, Cassin BJ, Powell J, Montie JA, Pontes JE and Crissman JD. (1995). Pathol. Res. Pract., 191, 838-841.
50. Sakr WA, Haas GP, Cassin BF, Pontes JE and Crissman JD. (1993). J. Urol., 150, 379-385.
51. Sakr WA and Partin AW. (2001). Urology, 57, 115-120.
52. Scates DK, Muir GH, Venitt S and Carmichael PL. (1997). Br. J. Urol., 80, 263-268.
53. Shackney SE, Berg G, Simon SR, Cohen J, Amina S, Pommersheim W, Yakulis R, Wang S, Uhl M, Smith CA, PoUice AA and Hartstock RJ. (1995). Cytometry, 22, 307-316.
54. Takahashi C, Miyagawa I, Kumano S and Oshimura M. (1997). Eur. Urol., 32, 494-498.
55. Takahashi S, Alcaraz A, Brown JA, Borell TJ, Herath JF, Bergstralh EJ, Lieber MM and Jenkins RB. (1996). Clin. Cancer Res., 2, 137-145.
56. van der Kwast TH, Labrie F and Tetu B. (1999). Eur. Urol., 35, 508-510.
57. Wen J, Cong YS and Bacchetti S. (1998). Hum. Mol. Genet., 7, 1137-1141.
58. Wullich B, Rohde V, Oehlenschlager B, Bonkhoff H, Ketter R, Zwergel T and Sattler HP. (1999). J. Urol., 161, 1997-2001.
59. Zhang W, Kapusta LR, Slingerland JM and Klotz LH. (1998). Cancer Res., 58, 619-621.